BHVN Q3 2020 Earnings — Biohaven Ltd. Revenue & Financial Results | Market Cap Arena

BHVNBiohaven Ltd.

$1B

Q3 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$18M

Gross Profit

$13M76.0% margin

Operating Income

-$163M-923.7% margin

Net Income

-$195M-1105.0% margin

EPS (Diluted)

$-3.27

QoQ Revenue Growth

+82.1%

Balance Sheet

Total Assets

$782M

Total Liabilities

$936M

Stockholders' Equity

-$212M

Cash & Equivalents

$316M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$18M	$0	—
Gross Profit	$13M	$0	—
Operating Income	-$163M	-$90M	-80.4%
Net Income	-$195M	-$106M	-83.9%